These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 31825249)

  • 1. Cariprazine Augmentation in Treatment-Resistant Bipolar Depression: Data from a Retrospective Observational Study.
    Teobaldi E; Pessina E; Martini A; Cattaneo CI; De Berardis D; Martiadis V; Maina G; Rosso G
    Curr Neuropharmacol; 2024; 22(10):1742-1748. PubMed ID: 38288838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of formulary-related pharmacy claim rejections of cariprazine on health care utilization and treatment patterns among patients with bipolar I disorder.
    Laliberté F; Zanardo E; MacKnight SD; Urosevic A; Wade SW; Parikh M
    J Manag Care Spec Pharm; 2024 Feb; 30(2):118-128. PubMed ID: 38308622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cariprazine as a Treatment Option for Depressive Episodes Associated with Bipolar 1 Disorder in Adults: An Evidence-Based Review of Recent Data.
    Tohen M
    Drug Des Devel Ther; 2021; 15():2005-2012. PubMed ID: 34012253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacology study of cariprazine (MP-214) in patients with schizophrenia (12-week treatment).
    Nakamura T; Kubota T; Iwakaji A; Imada M; Kapás M; Morio Y
    Drug Des Devel Ther; 2016; 10():327-38. PubMed ID: 26834462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cariprazine for treating coprophagia and organic psychosis in a young woman with acquired brain injury.
    Collison-Ani E; Faher A; Au M; Burrah G
    BMJ Case Rep; 2023 Jan; 16(1):. PubMed ID: 36593074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recommendation for a Therapeutic Reference Range of Cariprazine-A Short Communication.
    Sattaf F; Scherf-Clavel M; Unterecker S; Reif A; Hahn M
    Ther Drug Monit; 2024 Apr; 46(2):270-273. PubMed ID: 38018849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case series of serious and unexpected adverse drug reactions under treatment with cariprazine.
    Heck J; Seifert J; Stichtenoth DO; Schroeder C; Groh A; Szycik GR; Degner D; Adamovic I; Schneider M; Glocker C; Rüther E; Bleich S; Grohmann R; Toto S
    Clin Case Rep; 2021 May; 9(5):e04084. PubMed ID: 34084502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mania Associated With Cariprazine: A Case Report and a Review of Literature Regarding Bipolar Depression Treatment With Cariprazine.
    Paulino Ferreira LP; Martins Batista C; Machado Nogueira JC; Silva Aleixo MA
    J Clin Psychopharmacol; 2024 Jul; ():. PubMed ID: 39008888
    [No Abstract]   [Full Text] [Related]  

  • 9. Revisiting cariprazine for bipolar I disorder maintenance treatment.
    Price MZ; Price RL
    Bipolar Disord; 2024 May; ():. PubMed ID: 38750650
    [No Abstract]   [Full Text] [Related]  

  • 10. A pooled post hoc analysis evaluating the safety and tolerability of cariprazine in bipolar depression.
    Earley WR; Burgess M; Rekeda L; Hankinson A; McIntyre RS; Suppes T; Calabrese JR; Yatham LN
    J Affect Disord; 2020 Feb; 263():386-395. PubMed ID: 31969269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Broad Efficacy of Cariprazine on Depressive Symptoms in Bipolar Disorder and the Clinical Implications.
    Yatham LN; Vieta E; McIntyre RS; Jain R; Patel M; Earley W
    Prim Care Companion CNS Disord; 2020 Sep; 22(5):. PubMed ID: 32942346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of Cariprazine in Acute Management of Psychiatric Disorders: a Meta-Analysis of Randomized Controlled Trials.
    Cooper H; Mishriky R; Reyad AA
    Psychiatr Danub; 2020; 32(1):36-45. PubMed ID: 32303028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cariprazine as a treatment across the bipolar I spectrum from depression to mania: mechanism of action and review of clinical data.
    Stahl SM; Laredo S; Morrissette DA
    Ther Adv Psychopharmacol; 2020; 10():2045125320905752. PubMed ID: 32110377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of cariprazine in the treatment of bipolar I and II depression: a randomized, double-blind, placebo-controlled, phase 2 trial.
    Yatham LN; Vieta E; Earley W
    Int Clin Psychopharmacol; 2020 May; 35(3):147-156. PubMed ID: 32058426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics, Safety, and Tolerability of Cariprazine in Pediatric Patients with Bipolar I Disorder or Schizophrenia.
    Riccobene T; Riesenberg R; Yeung PP; Earley WR; Hankinson AL
    J Child Adolesc Psychopharmacol; 2022 Oct; 32(8):434-443. PubMed ID: 36282772
    [No Abstract]   [Full Text] [Related]  

  • 16. Cariprazine Safety in Adolescents and the Elderly: Analyses of Clinical Study Data.
    Szatmári B; Barabássy Á; Harsányi J; Laszlovszky I; Sebe B; Gál M; Shiragami K; Németh G
    Front Psychiatry; 2020; 11():61. PubMed ID: 32194443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine in Autism Spectrum Disorders-Focus on D2/D3 Partial Agonists and Their Possible Use in Treatment.
    Mandic-Maravic V; Grujicic R; Milutinovic L; Munjiza-Jovanovic A; Pejovic-Milovancevic M
    Front Psychiatry; 2021; 12():787097. PubMed ID: 35185637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Interventions to Mitigate Mitochondrial Dysfunction and Oxidative Stress-Induced Damage in Patients with Bipolar Disorder.
    Madireddy S; Madireddy S
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cariprazine in Youth with Bipolar and Psychotic Disorders: A Retrospective Chart Review.
    Poweleit EA; Colestock M; Kantemneni EC; Strawn JR; Patino LR; DelBello MP; Ramsey LB
    J Child Adolesc Psychopharmacol; 2020 May; 30(4):267-272. PubMed ID: 31825249
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.